0000899243-19-026381.txt : 20191030 0000899243-19-026381.hdr.sgml : 20191030 20191030200208 ACCESSION NUMBER: 0000899243-19-026381 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20191030 FILED AS OF DATE: 20191030 DATE AS OF CHANGE: 20191030 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: OYSTER POINT PHARMA I, LLC CENTRAL INDEX KEY: 0001769046 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39112 FILM NUMBER: 191181615 BUSINESS ADDRESS: STREET 1: 11 LINDA ISLE CITY: NEWPORT BEACH STATE: CA ZIP: 92660 BUSINESS PHONE: 714-299-1864 MAIL ADDRESS: STREET 1: 11 LINDA ISLE CITY: NEWPORT BEACH STATE: CA ZIP: 92660 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Oyster Point Pharma, Inc. CENTRAL INDEX KEY: 0001720725 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 811030955 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 202 CARNEGIE CENTER STREET 2: SUITE 109 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: (609) 382-9032 MAIL ADDRESS: STREET 1: 202 CARNEGIE CENTER STREET 2: SUITE 109 CITY: PRINCETON STATE: NJ ZIP: 08540 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2019-10-30 0 0001720725 Oyster Point Pharma, Inc. OYST 0001769046 OYSTER POINT PHARMA I, LLC 11 LINDA ISLE NEWPORT BEACH CA 92660 0 0 1 0 Series B Convertible Preferred Stock Common Stock, par value $0.001 per share 955392 D These shares of Series B Convertible Preferred Stock will automatically be converted into shares of the Issuer's Common Stock, on a one-for-one basis, immediately prior to the completion of the Issuer's initial public offering. The Series B Convertible Preferred Stock has no expiration date. Consists of 955,392 shares of common stock beneficially owned by Oyster Point Pharma I, LLC. William J. Link, as a managing partner of Oyster Point Pharma I, LLC, may be deemed to share voting and dispositive power over the shares held by Oyster Point Pharma I, LLC. Exhibit 24 - Power of Attorney /s/ Jeffrey Nau, Attorney-in-fact 2019-10-30 EX-24 2 attachment1.htm EX-24 DOCUMENT

                               POWER OF ATTORNEY

       The undersigned, as a Section 16 reporting person of Oyster Point Pharma,
Inc. (the "Company"), hereby constitutes and appoints Jeffrey Nau and Daniel
Lochner and each of them, as the undersigned's true and lawful attorney-in-fact
to:

       1.  complete and execute Forms 3, 4 and 5 and other forms and all
           amendments thereto as such attorney-in-fact shall in his discretion
           determine to be required or advisable pursuant to Section 16 of the
           Securities Exchange Act of 1934 (as amended) and the rules and
           regulations promulgated thereunder, or any successor laws and
           regulations, as a consequence of the undersigned's ownership,
           acquisition or disposition of securities of the Company; and

       2.  do all acts necessary in order to file such forms with the Securities
           and Exchange Commission, any securities exchange or national
           association, the Company and such other person or agency as the
           attorneys-in-fact shall deem appropriate.

       The undersigned hereby ratifies and confirms all that said attorneys-in-
fact and agents shall do or cause to be done by virtue hereof. The undersigned
acknowledges that the foregoing attorneys-in-fact, in serving in such capacity
at the request of the undersigned, are not assuming, nor is the Company
assuming, any of the undersigned's responsibilities to comply with Section 16 of
the Securities Exchange Act of 1934 (as amended).

       This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
Company and the foregoing attorneys-in-fact.

       IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of this 28th day of October, 2019.


                                              OYSTER POINT PHARMA I, LLC

                                              By: /s/ William J. Link, PhD.
                                                  -------------------------
                                              Name: William J. Link, PhD.

                                              Title: Manager